RGD Reference Report - The mitochondrial 13513G>A mutation is associated with Leigh disease phenotypes independent of complex I deficiency in muscle. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

The mitochondrial 13513G>A mutation is associated with Leigh disease phenotypes independent of complex I deficiency in muscle.

Authors: Brautbar, A  Wang, J  Abdenur, JE  Chang, RC  Thomas, JA  Grebe, TA  Lim, C  Weng, SW  Graham, BH  Wong, LJ 
Citation: Brautbar A, etal., Mol Genet Metab. 2008 Aug;94(4):485-90. Epub 2008 May 20.
RGD ID: 5491185
Pubmed: PMID:18495510   (View Abstract at PubMed)
DOI: DOI:10.1016/j.ymgme.2008.04.004   (Journal Full-text)

The mitochondrial 13513G>A (D393N) mutation in the ND5 subunit of the respiratory chain complex I was initially described in association with MELAS syndrome. Recent observations have linked this mutation to Leigh disease. We screened for the 13513G>A mutation in a cohort of 265 patients with Leigh and Leigh-like disease. The mutation was found in a total of 5 patients. An additional patient who had clinical presentation consistent with a Leigh-like phenotype but with a normal brain MRI was added to the cohort. None of an additional 88 patients meeting MELAS disease criteria, nor 56 patients with respiratory chain deficiency screened for the 13513G>A were found positive for the mutation. The most frequent clinical manifestations in our patients were hypotonia, ocular and cerebellar involvement. Low mutation heteroplasmy in the range of 20-40% was observed in all 6 patients. This observation is consistent with the previously reported low heteroplasmy of this mutation in some patients with the 13513G>A mutation and complex I deficiency. However, normal complex I activity was observed in two patients in our cohort. As most patients with Leigh-like disease and the 13513G>A mutation have been described with complex I deficiency, this report adds to the previously reported subset of patients with normal respiratory complex function. We conclude that in any patient with Leigh or Leigh-like disease, testing for the 13513G>A mutation is clinically relevant and low mutant loads in blood or muscle may be considered pathogenic, in the presence of normal respiratory chain enzyme activities.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
Leigh disease  IAGP 5491185DNA:mutation: exon:m.13513 G>A (D393N)(human)RGD 
Leigh disease  ISOMT-ND5 (Homo sapiens)5491185; 5491185DNA:mutation: exon:m.13513 G>A (D393N)(human)RGD 

Objects Annotated

Genes (Rattus norvegicus)
Mt-nd5  (mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5)

Genes (Mus musculus)
mt-Nd5  (NADH dehydrogenase 5, mitochondrial)

Genes (Homo sapiens)
MT-ND5  (mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5)


Additional Information